|
May 14
|
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?
|
|
May 13
|
2 Biotech Stocks That Are Screaming Buys in May
|
|
May 12
|
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
|
|
May 10
|
3 Monster Stocks to Hold for the Next 10 Years
|
|
May 8
|
CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million
|
|
May 8
|
Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet
|
|
May 8
|
CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations
|
|
May 7
|
CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock Tanks
|
|
May 7
|
We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate
|
|
May 6
|
CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3
|
|
May 5
|
Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?
|
|
Apr 7
|
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
|
|
Apr 7
|
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
|
|
Apr 5
|
CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation
|
|
Apr 4
|
CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know
|
|
Apr 3
|
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
|
|
Apr 3
|
CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
|
|
Mar 14
|
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
|
|
Mar 13
|
Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?
|
|
Mar 11
|
ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics
|